The listing caps a six-year run with Qiming as one of Alamar’s core venture backers.
Written by IPO Zaozhidao
Published on
21 Apr 2026
2 mins read
Qiming Venture Partners has recorded its fifth IPO within its portfolio since the start of the year, after Alamar Biosciences officially began trading on Nasdaq on April 17.
The 15-year-old chipmaker saw its shares climb 61% above its IPO price by the close of its first trading day.
Chime raises $864 mln with IPO, but management doesn’t sell shares.
It could become the first publicly listed company focused on AI-driven nanodelivery.
Quantinuum has filed for an initial public offering less than a year after a $600m round valued it at $10bn.
Shuimu BioSciences is the first Chinese company to develop its own cryo-electron microscopy machine, a vital tool in drug…
Nord Quantique has closed a $30 million growth equity investment round, elevating the company’s pre-money valuation to $1.4…
